Carrie Bailey

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +3

Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease

Suhrad G. Banugaria, Sean N. Prater, Judeth K. McGann et al. · Genetics in Medicine · 2012 · 86 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks

Priya S. Kishnani, Jordi Díaz‐Manera, António Toscano et al. · JAMA Neurology · 2023 · 55 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +8

An Examination of the Relationships Between Ego Development, Dabrowski’s Theory of Positive Disintegration, and the Behavioral Characteristics of Gifted Adolescents

Carrie Bailey · Gifted Child Quarterly · 2011 · 47 citations · Full text

Education, Counseling, Psychology +7

Anaplerotic therapy in propionic acidemia

Nicola Longo, Leisa B. Price, Eduard Gappmaier et al. · Molecular Genetics and Metabolism · 2017 · 41 citations · Full text

Life Sciences, Biochemistry, Physiology +7